Ovation Science to Present at the Virtual Gravitas Securities Healthcare Investor Day, Thursday, Oct 1st at 3:45pm EST

VANCOUVER, BC / ACCESSWIRE / September 30, 2020 / Ovation Science Inc.(CSE:OVAT), a topical research and development company with a patented drug delivery technology backed by over 20 years of research and development and helping the fight against COVID-19 with its unique hand sanitizer DermSafe®, is pleased to announce it will be participating in the Gravitas Healthcare Investor Day taking place Thursday, October 1st, 2020 virtually.

Ovation’s President, Terry Howlett, is scheduled to present on Thursday, October 1st at 3:45 PM EST / 12:45 PM PST. Mr. Howlett will also be fielding investor questions during the one-day virtual conference hosted by Gravitas Securities Inc. “I am looking forward to sharing our growth strategy with investors at the Gravitas Healthcare Investor Day,” said Mr. Howlett. “With Ovation’s launch of DermSafe® Hand Sanitizer generating a new revenue stream, the Gravitas Healthcare Investor Day is an ideal venue to communicate our progress to investors.”

This year’s Gravitas Healthcare Investor Day will feature several leaders in healthcare and will be attended virtually by institutional and retail investors from North America and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com

Conference Details:

Event: Gravitas Healthcare Investor Day (Virtual)
Format: Presentation
Date: Thursday, October 1st
Time: 3:45 PM EST
Registration: CLICK Link to register

Ovation Science Inc.
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees and now revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT. Visit our website www.ovationscience.com.

For information about DermSafe and to order visit: https://dermsafe.com

For information about Ovation Science products visit: https://ovationscience.com/products/.

Statements have not been evaluated by Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

INVESTOR RELATIONS:
Sebastian Kunysz: ovat@kincommunications.com Phone: 604-684-6730 or Toll Free at 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:
Doreen McMorran: doreen@ovationscience.com Phone: 604-283-0903 ext. 4

SOURCE: Ovation Science Inc.

View source version on accesswire.com:
https://www.accesswire.com/608390/Ovation-Science-to-Present-at-the-Virtual-Gravitas-Securities-Healthcare-Investor-Day-Thursday-Oct-1st-at-345pm-EST